DCF Advisers, LLC
Source: SEC Form 13F · as of Mar 2026DCF Advisers, LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $48.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$48.9M
BioSniper AIPage context preserved
Prepared research question
What matters most for ARGENX SE (ARGX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ARGXARGENX SE | 14,650 | $10.7M |
| TEVATeva Pharmaceutical Industries Limited | 300,000 | $9.0M |
| REGNREGENERON PHARMACEUTICALS, INC. | 9,250 | $7.1M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 160,600 | $5.1M |
| IONSIONIS PHARMACEUTICALS INC | 56,000 | $4.2M |
| INCYIncyte Corp. | 41,500 | $3.9M |
| EVOEvotec SE | 1,065,274 | $2.7M |
| GPCRStructure Therapeutics Inc. | 27,500 | $1.3M |
| BHVNBiohaven Ltd. | 123,500 | $1.0M |
| ANABANAPTYSBIO, INC | 18,775 | $1.0M |
| QUREuniQure N.V. | 49,000 | $801K |
| PRTAPROTHENA CORP PUBLIC LTD CO | 73,247 | $712K |
| VRDNViridian Therapeutics, Inc.\DE | 32,150 | $629K |
| CMPSCOMPASS Pathways plc | 42,500 | $235K |
| IFRXInflaRx N.V. | 158,500 | $142K |
| ARDXARDELYX, INC. | 20,000 | $120K |
| ALTAltimmune, Inc. | 14,700 | $45K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.